These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22649373)

  • 21. Childhood antecedents to adult cardiovascular disease.
    Halfon N; Verhoef PA; Kuo AA
    Pediatr Rev; 2012 Feb; 33(2):51-60; quiz 61. PubMed ID: 22301031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing macrovascular disease in patients with type 2 diabetes mellitus.
    Johansen OE; Birkeland KI
    Am J Cardiovasc Drugs; 2003; 3(4):283-97. PubMed ID: 14728081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence.
    Sosale A; Saboo B; Sosale B
    Diabetes Metab Syndr Obes; 2015; 8():189-96. PubMed ID: 25926748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prevention in high-risk dyslipidemic patients without an established cardiovascular disease: Undertreatment and rationale for lipid-lowering therapy.
    Zafrir B; Cohen S
    Eur J Intern Med; 2006 Nov; 17(7):495-9. PubMed ID: 17098594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018.
    Panozzo CA; Curtis LH; Marshall J; Fine L; Wells BL; Brown JS; Haynes K; Pawloski PA; Hernandez AF; Malek S; Syat B; Platt R
    PLoS One; 2019; 14(12):e0223515. PubMed ID: 31805056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbidity complicates cardiovascular treatment: is diabetes the exception?
    Nouwens E; van Lieshout J; Wensing M
    Neth J Med; 2012 Sep; 70(7):298-305. PubMed ID: 22961822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.
    De Rosa S; Arcidiacono B; Chiefari E; Brunetti A; Indolfi C; Foti DP
    Front Endocrinol (Lausanne); 2018; 9():2. PubMed ID: 29387042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
    Perera R; McFadden E; McLellan J; Lung T; Clarke P; Pérez T; Fanshawe T; Dalton A; Farmer A; Glasziou P; Takahashi O; Stevens J; Irwig L; Hirst J; Stevens S; Leslie A; Ohde S; Deshpande G; Urayama K; Shine B; Stevens R
    Health Technol Assess; 2015 Dec; 19(100):1-401, vii-viii. PubMed ID: 26680162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.
    Kalofoutis C; Piperi C; Kalofoutis A; Harris F; Phoenix D; Singh J
    Exp Clin Cardiol; 2007; 12(1):17-28. PubMed ID: 18650975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors.
    Gerich JE
    Clin Cornerstone; 2007; 8(3):53-68. PubMed ID: 18452842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.
    Ouyang XJ; Zhang YQ; Chen JH; Li T; Lu TT; Bian RW
    Chin Med J (Engl); 2018 Feb; 131(3):295-300. PubMed ID: 29363644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.
    Müller-Wieland D; Leiter LA; Cariou B; Letierce A; Colhoun HM; Del Prato S; Henry RR; Tinahones FJ; Aurand L; Maroni J; Ray KK; Bujas-Bobanovic M
    Cardiovasc Diabetol; 2017 May; 16(1):70. PubMed ID: 28545518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective.
    Mahmood D; Jahan K; Habibullah K
    J Saudi Heart Assoc; 2015 Jul; 27(3):179-91. PubMed ID: 26136632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Critical analysis of the American Diabetes Association dietary recommendations for cardiovascular disease in diabetes mellitus].
    Santos AL; Weiss T; Duarte CK; Azevedo MJ; Zelmanovitz T
    Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):657-66. PubMed ID: 19768256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease risk in individuals with chronic spinal cord injury: Prevalence of untreated risk factors and poor adherence to treatment guidelines.
    Chopra AS; Miyatani M; Craven BC
    J Spinal Cord Med; 2018 Jan; 41(1):2-9. PubMed ID: 27077567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease.
    Chamberlain AM; Cohen SS; Killian JM; Monda KL; Weston SA; Okerson T
    Am J Cardiol; 2019 Oct; 124(7):995-1001. PubMed ID: 31362878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and early detection of cardiovascular disease in South Asians with diabetes mellitus.
    Wander GS; Bansal M; Kasliwal RR
    Diabetes Metab Syndr; 2020; 14(4):385-393. PubMed ID: 32334394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.